
Morocco unveils policies it hopes bolster the care and management of stray dogs
The 'Beldi,' as Moroccan street dogs are called, is among the hundreds taken from Rabat to a dog pound in a nearby forest. As part of an expanded 'Trap, Neuter, Vaccinate and Return' program, dogs like her are examined, treated and ultimately released with tags that make clear they pose no danger.
'We have a problem: That's stray dogs. So we have to solve it, but in a way that respects animals,' said Mohamed Roudani, the director of the Public Health and Green Spaces Department in Morocco's Interior Ministry.
Trying to balance safety and animal well-being
Morocco
adopted 'Trap, Neuter, Vaccinate and Return,' or TVNR, in 2019. One facility has opened in Rabat and more are set to be launched in at least 14 other cities, aligning Morocco with recommendations from the World Organization for Animal Health. The government has spent roughly $23 million over the past five years on animal control centers and programs.
Roudani said Morocco's updated approach balanced public safety, health and animal well-being. Local officials, he added, were eager to expand TVNR centers throughout the country.
Though population estimates are challenging, based on samples of marked and tagged stray dogs, Moroccan officials believe they number between 1.2 to 1.5 million. Some neighborhoods welcome and care for them collectively. However, others decry their presence as a scourge and note that more than 100,000 Moroccans have needed rabies vaccinations after attacks.
A draft law is in the works that would require owners to vaccinate pets and impose penalties for animal abuse.
Inside the center
On a visit organized for journalists to a TNVR center in El Aarjate, enclosures for dogs appear spacious and orderly, with clean floors and the scent of disinfectant. Food and water bowls are refreshed regularly by staff who move between spaces, offering gentle words and careful handling. Some staff members say they grow so attached to the dogs that they miss them when they're released to make space to treat incoming strays.
Veterinarians and doctors working for the Association for the Protection of Animals and Nature care for between 400 and 500 stray dogs from Rabat and surrounding cities. Dogs that veterinarians deem unhealthy or aggressive are euthanized using sodium pentobarbital, while the rest are released, unable to spread disease or reproduce.
Youssef Lhor, a doctor and veterinarian, said that aggressive methods to cull dogs didn't effectively make communities safer from rabies or aggression. He said it made more sense to to try to have people coexist with dogs safely, noting that more than 200 had been released after treatment from the Rabat-area center.
'Slaughtering dogs leads to nothing. This TNVR strategy is not a miracle solution, but it is an element that will add to everything else we're doing,' he said, referring to 'Treat, Neuter, Vaccinate, Return.'
It's designed to gradually reduce the stray dog population while minimizing the need for euthanasia.
It's a program that Morocco is eager to showcase after animal rights groups accused it of ramping up efforts to cull street dogs after
being named co-host
of the 2030 FIFA World Cup last year.
Animal rights groups protest
Animal rights groups routinely use large sporting events to draw attention to their cause and
similarly targeted Russia
in the lead-up to the 2018 FIFA World Cup there.
Citing unnamed sources and videos it said were shot in Morocco, the International Animal Welfare and Protection Coalition claimed in January that Morocco was exterminating 3 million dogs, particularly around cities where stadiums are being built. The allegations, reported widely by international media lacking a presence in Morocco, triggered anti-FIFA protests as far away as Ahmedabad, India.
'These dogs are being shot in the street, often in front of children, or dragged away with wire nooses to die slow, agonizing deaths,' Ian Ward, the coalition's chairman, said in a statement.
Moroccan officials vehemently deny the claims, say they're implementing the very programs that activists propose, including TNVR. They rebuff the idea that any policy is related to the World Cup. Still, critics see their efforts as publicity stunts and are skeptical such programs are as widespread as officials claim.
Instances of mistreatment and euthanasia by gunshot have been reported
in local media
but Moroccan officials say, despite international attention, they're isolated incidents and don't reflect on-the-ground reality nationwide.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
EU regulator approves injectable HIV drug that experts say could help stop transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is 'highly effective' and 'considered to be of major public health interest.' Once the regulator's guidance is accepted by the European Commission, the authorization is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein. Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping transmission in both women and men. Winnie Byanyima, executive director of the U.N. AIDS agency, has said the drug 'could change the trajectory of the HIV epidemic' if it is made available to everyone who needs it. In June, the U.S. Food and Drug Administration authorized lenacapavir to prevent HIV. Earlier this month, the World Health Organization recommended countries offer the drug as an additional option to people at risk of the virus. Condoms help guard against HIV infection if used properly. Other medication aimed at preventing HIV include daily pills that people can take and another injectable drug called cabotegravir, which is given every two months. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more visits to health clinics or stigma from taking daily pills. Critics have raised concerns, however, that lenacapavir may not be made widely enough available to stop global outbreaks of HIV. Drugmaker Gilead has said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates — mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease. Last year, there were about 630,000 AIDS deaths worldwide and more than 40 million people are estimated to have HIV, according to UNAIDS. UNAIDS chief Byanyima has previously suggested the U.S. President Donald Trump make a deal with Gilead to produce and license its 'magical' prevention drug lenacapavir across the world to the millions of people who need it. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. The Associated Press
Yahoo
23 minutes ago
- Yahoo
Wisconsin Lt. Gov. Sara Rodriguez becomes the first Democrat to enter the 2026 governor race
MADISON, Wis. (AP) — Wisconsin Democratic Lt. Gov. Sara Rodriguez, a former emergency room nurse, announced Friday that she is running for governor, the day after the incumbent decided against seeking a third term. Rodriguez is the first Democrat to officially enter the 2026 race. Several others are considering running after Gov. Tony Evers said Thursday he was bowing out. Wisconsin's 2026 governor's race is open with no incumbent running for the first time since 2010. Rodriguez, who almost certainly will face numerous Democratic primary opponents, has vowed to push back against Republican President Donald Trump's administration. 'We've got a maniac in the White House,' Rodriguez said in a campaign launch video. 'His tariffs are killing our farmers and his policies are hurting our kids.' Rodriguez has been lieutenant governor since 2023, after previously serving one two-year term in the state Assembly representing suburban Milwaukee, where she lives. She won a seat that had been under Republican control for years. Rodriguez emphasized her background working previously as a nurse in a Baltimore emergency room, saying she wanted to continue Evers' emphasis on fighting to protect reproductive freedom, invest in public schools and rebuild the economy. She noted that the state Legislature is within reach of Democratic control, meaning that with a Democratic governor, they could finally enact policies Republicans have blocked for years like expanding Medicaid. A registered nurse, Rodriguez previously worked as a health care executive and an epidemic intelligence service officer with the Centers for Disease Control and Prevention. She has a master's degree in public health. Rodriguez emphasized the importance of health care, including protecting abortion rights, in a brief speech she delivered on the first night of the Democratic National Convention in Chicago last year. Rodriguez, who is married with two children, launched her candidacy on her 50th birthday. In her first run for office in 2020, when she was elected to the Legislature, Rodriguez said she was motivated to get into politics because of how Republicans handled the COVID-19 pandemic. Rodriguez won the Democratic primary for lieutenant governor in 2022 after then-Lt. Gov. Mandela Barnes, who held the office in Evers' first term, decided to run for the Senate. Barnes, who lost that race to Republican Sen. Ron Johnson, is among several Democrats considering a run for governor next year. Others include Attorney General Josh Kaul, state Sen. Kelda Roys, Secretary of State Sarah Godlewski, Milwaukee Mayor Cavalier Johnson and Milwaukee County Executive David Crowley. On the Republican side, Washington County Executive Josh Schoemann and suburban Milwaukee businessman Bill Berrien are the only announced candidates. Others, including U.S. Rep. Tom Tiffany and state Senate President Mary Felzkowski, are considering it. Solve the daily Crossword

Associated Press
25 minutes ago
- Associated Press
EU regulator approves injectable HIV drug that experts say could help stop transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission. In a statement on Friday, the EU drug regulator said its evaluations of lenacapavir, sold as Yeytuo in Europe by Gilead Sciences, showed the drug is 'highly effective' and 'considered to be of major public health interest.' Once the regulator's guidance is accepted by the European Commission, the authorization is valid in all 27 EU member countries as well as Iceland, Norway and Liechtenstein. Last year, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping transmission in both women and men. Winnie Byanyima, executive director of the U.N. AIDS agency, has said the drug 'could change the trajectory of the HIV epidemic' if it is made available to everyone who needs it. In June, the U.S. Food and Drug Administration authorized lenacapavir to prevent HIV. Earlier this month, the World Health Organization recommended countries offer the drug as an additional option to people at risk of the virus. Condoms help guard against HIV infection if used properly. Other medication aimed at preventing HIV include daily pills that people can take and another injectable drug called cabotegravir, which is given every two months. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more visits to health clinics or stigma from taking daily pills. Critics have raised concerns, however, that lenacapavir may not be made widely enough available to stop global outbreaks of HIV. Drugmaker Gilead has said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates — mostly in Africa, Southeast Asia and the Caribbean. But it has excluded nearly all of Latin America, where rates are far lower but increasing, sparking concern the world is missing a critical opportunity to stop the disease. Last year, there were about 630,000 AIDS deaths worldwide and more than 40 million people are estimated to have HIV, according to UNAIDS. UNAIDS chief Byanyima has previously suggested the U.S. President Donald Trump make a deal with Gilead to produce and license its 'magical' prevention drug lenacapavir across the world to the millions of people who need it. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.